The group's principle activity is to operate outpatient vascular access centers for patients suffering from end-stage renal disease or kidney failure. The company offers interventional services, fistulogram/angioplasty, thrombectomy, and catheter placement and replacement; vascular access surveillance programs; venous laser treatment; and diagnostic and interventional services. The group operates from United States.
